http://new.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 06 Jul 2026 07:00:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://new.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Grey+Matters+Takes+Delivery+of+the+First+Brain+Dedicated+PET+Scanning+System+for+its+Flagship+NovaScan+Neuroimaging+Clinic+in+Florida/26732535.html <p align="justify">VANCOUVER, British Columbia, July 06, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the “Company” or “Grey Matters”) (CSE: GREY) (FRANKFURT: AGW0) (OTC: AGNPF), a Canadian healthcare company, is pleased to announce that it has taken delivery of its first brain dedicated PET (Positron Emission Tomography) scanning system for its flagship NovaScan Neuroimaging ClinicsTM location, opening soon in Davie, Florida.</p> <p align="justify">The clinic will be the first of its kind in the U.S. to offer brain only PET scanning to assist in meeting the growing demand for early Alzheimer’s detection through beta-amyloid imaging, and to provide http://www.streetinsider.com/Press+Releases/Grey+Matters+Takes+Delivery+of+the+First+Brain+Dedicated+PET+Scanning+System+for+its+Flagship+NovaScan+Neuroimaging+Clinic+in+Florida/26732535.html Mon, 06 Jul 2026 07:00:00 -0400 AGN AGNPF AGW0 GREY O.31280495 http://www.streetinsider.com/Press+Releases/Grey+Matters+Takes+Delivery+of+the+First+Brain+Dedicated+PET+Scanning+System+for+its+Flagship+NovaScan+Neuroimaging+Clinic+in+Florida/26732535.html <p align="justify">VANCOUVER, British Columbia, July 06, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the “Company” or “Grey Matters”) (CSE: GREY) (FRANKFURT: AGW0) (OTC: AGNPF), a Canadian healthcare company, is pleased to announce that it has taken delivery of its first brain dedicated PET (Positron Emission Tomography) scanning system for its flagship NovaScan Neuroimaging ClinicsTM location, opening soon in Davie, Florida.</p> <p align="justify">The clinic will be the first of its kind in the U.S. to offer brain only PET scanning to assist in meeting the growing demand for early Alzheimer’s detection through beta-amyloid imaging, and to provide http://www.streetinsider.com/Press+Releases/Grey+Matters+Takes+Delivery+of+the+First+Brain+Dedicated+PET+Scanning+System+for+its+Flagship+NovaScan+Neuroimaging+Clinic+in+Florida/26732535.html Mon, 06 Jul 2026 07:00:00 -0400 AGN AGNPF AGW0 GREY O.31280495 http://www.streetinsider.com/Press+Releases/Grey+Matters+Takes+Delivery+of+the+First+Brain+Dedicated+PET+Scanning+System+for+its+Flagship+NovaScan+Neuroimaging+Clinic+in+Florida/26732535.html <p align="justify">VANCOUVER, British Columbia, July 06, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the “Company” or “Grey Matters”) (CSE: GREY) (FRANKFURT: AGW0) (OTC: AGNPF), a Canadian healthcare company, is pleased to announce that it has taken delivery of its first brain dedicated PET (Positron Emission Tomography) scanning system for its flagship NovaScan Neuroimaging ClinicsTM location, opening soon in Davie, Florida.</p> <p align="justify">The clinic will be the first of its kind in the U.S. to offer brain only PET scanning to assist in meeting the growing demand for early Alzheimer’s detection through beta-amyloid imaging, and to provide http://www.streetinsider.com/Press+Releases/Grey+Matters+Takes+Delivery+of+the+First+Brain+Dedicated+PET+Scanning+System+for+its+Flagship+NovaScan+Neuroimaging+Clinic+in+Florida/26732535.html Mon, 06 Jul 2026 07:00:00 -0400 AGN AGNPF AGW0 GREY O.31280495 http://www.streetinsider.com/Press+Releases/Grey+Matters+Takes+Delivery+of+the+First+Brain+Dedicated+PET+Scanning+System+for+its+Flagship+NovaScan+Neuroimaging+Clinic+in+Florida/26732535.html <p align="justify">VANCOUVER, British Columbia, July 06, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the “Company” or “Grey Matters”) (CSE: GREY) (FRANKFURT: AGW0) (OTC: AGNPF), a Canadian healthcare company, is pleased to announce that it has taken delivery of its first brain dedicated PET (Positron Emission Tomography) scanning system for its flagship NovaScan Neuroimaging ClinicsTM location, opening soon in Davie, Florida.</p> <p align="justify">The clinic will be the first of its kind in the U.S. to offer brain only PET scanning to assist in meeting the growing demand for early Alzheimer’s detection through beta-amyloid imaging, and to provide http://www.streetinsider.com/Press+Releases/Grey+Matters+Takes+Delivery+of+the+First+Brain+Dedicated+PET+Scanning+System+for+its+Flagship+NovaScan+Neuroimaging+Clinic+in+Florida/26732535.html Mon, 06 Jul 2026 07:00:00 -0400 AGN AGNPF AGW0 GREY O.31280495 http://www.streetinsider.com/Press+Releases/Grey+Matters+Takes+Delivery+of+the+First+Brain+Dedicated+PET+Scanning+System+for+its+Flagship+NovaScan+Neuroimaging+Clinic+in+Florida/26732535.html <p align="justify">VANCOUVER, British Columbia, July 06, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the “Company” or “Grey Matters”) (CSE: GREY) (FRANKFURT: AGW0) (OTC: AGNPF), a Canadian healthcare company, is pleased to announce that it has taken delivery of its first brain dedicated PET (Positron Emission Tomography) scanning system for its flagship NovaScan Neuroimaging ClinicsTM location, opening soon in Davie, Florida.</p> <p align="justify">The clinic will be the first of its kind in the U.S. to offer brain only PET scanning to assist in meeting the growing demand for early Alzheimer’s detection through beta-amyloid imaging, and to provide http://www.streetinsider.com/Press+Releases/Grey+Matters+Takes+Delivery+of+the+First+Brain+Dedicated+PET+Scanning+System+for+its+Flagship+NovaScan+Neuroimaging+Clinic+in+Florida/26732535.html Mon, 06 Jul 2026 07:00:00 -0400 AGN AGNPF AGW0 GREY O.31280495 http://www.streetinsider.com/Globe+Newswire/Grey+Matters+Takes+Delivery+of+the+First+Brain+Dedicated+PET+Scanning+System+for+its+Flagship+NovaScan+Neuroimaging+Clinic+in+Florida/26732535.html <p align="justify">VANCOUVER, British Columbia, July 06, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the “Company” or “Grey Matters”) (CSE: GREY) (FRANKFURT: AGW0) (OTC: AGNPF), a Canadian healthcare company, is pleased to announce that it has taken delivery of its first brain dedicated PET (Positron Emission Tomography) scanning system for its flagship NovaScan Neuroimaging ClinicsTM location, opening soon in Davie, Florida.</p> <p align="justify">The clinic will be the first of its kind in the U.S. to offer brain only PET scanning to assist in meeting the growing demand for early Alzheimer’s detection through beta-amyloid imaging, and to provide http://www.streetinsider.com/Globe+Newswire/Grey+Matters+Takes+Delivery+of+the+First+Brain+Dedicated+PET+Scanning+System+for+its+Flagship+NovaScan+Neuroimaging+Clinic+in+Florida/26732535.html Mon, 06 Jul 2026 07:00:00 -0400 AGN AGNPF AGW0 GREY O.31280495 http://www.streetinsider.com/Globe+Newswire/Grey+Matters+Takes+Delivery+of+the+First+Brain+Dedicated+PET+Scanning+System+for+its+Flagship+NovaScan+Neuroimaging+Clinic+in+Florida/26732535.html <p align="justify">VANCOUVER, British Columbia, July 06, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the “Company” or “Grey Matters”) (CSE: GREY) (FRANKFURT: AGW0) (OTC: AGNPF), a Canadian healthcare company, is pleased to announce that it has taken delivery of its first brain dedicated PET (Positron Emission Tomography) scanning system for its flagship NovaScan Neuroimaging ClinicsTM location, opening soon in Davie, Florida.</p> <p align="justify">The clinic will be the first of its kind in the U.S. to offer brain only PET scanning to assist in meeting the growing demand for early Alzheimer’s detection through beta-amyloid imaging, and to provide http://www.streetinsider.com/Globe+Newswire/Grey+Matters+Takes+Delivery+of+the+First+Brain+Dedicated+PET+Scanning+System+for+its+Flagship+NovaScan+Neuroimaging+Clinic+in+Florida/26732535.html Mon, 06 Jul 2026 07:00:00 -0400 AGN AGNPF AGW0 GREY O.31280495 http://www.streetinsider.com/Globe+Newswire/Grey+Matters+Takes+Delivery+of+the+First+Brain+Dedicated+PET+Scanning+System+for+its+Flagship+NovaScan+Neuroimaging+Clinic+in+Florida/26732535.html <p align="justify">VANCOUVER, British Columbia, July 06, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the “Company” or “Grey Matters”) (CSE: GREY) (FRANKFURT: AGW0) (OTC: AGNPF), a Canadian healthcare company, is pleased to announce that it has taken delivery of its first brain dedicated PET (Positron Emission Tomography) scanning system for its flagship NovaScan Neuroimaging ClinicsTM location, opening soon in Davie, Florida.</p> <p align="justify">The clinic will be the first of its kind in the U.S. to offer brain only PET scanning to assist in meeting the growing demand for early Alzheimer’s detection through beta-amyloid imaging, and to provide http://www.streetinsider.com/Globe+Newswire/Grey+Matters+Takes+Delivery+of+the+First+Brain+Dedicated+PET+Scanning+System+for+its+Flagship+NovaScan+Neuroimaging+Clinic+in+Florida/26732535.html Mon, 06 Jul 2026 07:00:00 -0400 AGN AGNPF AGW0 GREY O.31280495 http://www.streetinsider.com/Globe+Newswire/Grey+Matters+Takes+Delivery+of+the+First+Brain+Dedicated+PET+Scanning+System+for+its+Flagship+NovaScan+Neuroimaging+Clinic+in+Florida/26732535.html <p align="justify">VANCOUVER, British Columbia, July 06, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the “Company” or “Grey Matters”) (CSE: GREY) (FRANKFURT: AGW0) (OTC: AGNPF), a Canadian healthcare company, is pleased to announce that it has taken delivery of its first brain dedicated PET (Positron Emission Tomography) scanning system for its flagship NovaScan Neuroimaging ClinicsTM location, opening soon in Davie, Florida.</p> <p align="justify">The clinic will be the first of its kind in the U.S. to offer brain only PET scanning to assist in meeting the growing demand for early Alzheimer’s detection through beta-amyloid imaging, and to provide http://www.streetinsider.com/Globe+Newswire/Grey+Matters+Takes+Delivery+of+the+First+Brain+Dedicated+PET+Scanning+System+for+its+Flagship+NovaScan+Neuroimaging+Clinic+in+Florida/26732535.html Mon, 06 Jul 2026 07:00:00 -0400 AGN AGNPF AGW0 GREY O.31280495 http://www.streetinsider.com/Globe+Newswire/Grey+Matters+Takes+Delivery+of+the+First+Brain+Dedicated+PET+Scanning+System+for+its+Flagship+NovaScan+Neuroimaging+Clinic+in+Florida/26732535.html <p align="justify">VANCOUVER, British Columbia, July 06, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the “Company” or “Grey Matters”) (CSE: GREY) (FRANKFURT: AGW0) (OTC: AGNPF), a Canadian healthcare company, is pleased to announce that it has taken delivery of its first brain dedicated PET (Positron Emission Tomography) scanning system for its flagship NovaScan Neuroimaging ClinicsTM location, opening soon in Davie, Florida.</p> <p align="justify">The clinic will be the first of its kind in the U.S. to offer brain only PET scanning to assist in meeting the growing demand for early Alzheimer’s detection through beta-amyloid imaging, and to provide http://www.streetinsider.com/Globe+Newswire/Grey+Matters+Takes+Delivery+of+the+First+Brain+Dedicated+PET+Scanning+System+for+its+Flagship+NovaScan+Neuroimaging+Clinic+in+Florida/26732535.html Mon, 06 Jul 2026 07:00:00 -0400 AGN AGNPF AGW0 GREY O.31280495 http://www.streetinsider.com/SEC+Filings/Form++D++++++++++Grey+Matters+Health+Inc.+++++++++++++/26694308.html si-local-file:///var/storage/secattach/20260626/26694308.html http://www.streetinsider.com/SEC+Filings/Form++D++++++++++Grey+Matters+Health+Inc.+++++++++++++/26694308.html Fri, 26 Jun 2026 06:00:00 -0400 AGN AGNPD O.31280495 http://www.streetinsider.com/SEC+Filings/Form++D++++++++++Grey+Matters+Health+Inc.+++++++++++++/26694308.html si-local-file:///var/storage/secattach/20260626/26694308.html http://www.streetinsider.com/SEC+Filings/Form++D++++++++++Grey+Matters+Health+Inc.+++++++++++++/26694308.html Fri, 26 Jun 2026 06:00:00 -0400 AGN AGNPD O.31280495 http://www.streetinsider.com/SEC+Filings/Form++D++++++++++Grey+Matters+Health+Inc.+++++++++++++/26694308.html si-local-file:///var/storage/secattach/20260626/26694308.html http://www.streetinsider.com/SEC+Filings/Form++D++++++++++Grey+Matters+Health+Inc.+++++++++++++/26694308.html Fri, 26 Jun 2026 06:00:00 -0400 AGN AGNPD O.31280495 http://www.streetinsider.com/Press+Releases/Grey+Matters+Health+Signs+LOI+with+Catalyst+MedTech+for+200+Brain+PET+Scans+for+Alzheimer%E2%80%99s+Clinical+Trial+at+2nd+NovaScan+Location+Planned+for+Tampa/26524610.html <p align="justify">VANCOUVER, British Columbia, May 20, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the “<strong>Company</strong>” or “<strong>Grey Matters</strong>”) (CSE: GREY) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company, is pleased to announce that it has signed a non-binding Letter of Intent (LOI) with Catalyst MedTech (Catalyst), to provide a minimum of 200 brain Positron Emission Tomography (PET) scans for an upcoming Alzheimer’s Disease (AD) clinical trial, to be conducted by an international Contract Research Organization (CRO) specializing in AD research. The PET Scans will be performed at the Company’s NovaScan Neuroimaging Clinics™ second location planned for Tampa, Florida. http://www.streetinsider.com/Press+Releases/Grey+Matters+Health+Signs+LOI+with+Catalyst+MedTech+for+200+Brain+PET+Scans+for+Alzheimer%E2%80%99s+Clinical+Trial+at+2nd+NovaScan+Location+Planned+for+Tampa/26524610.html Wed, 20 May 2026 07:00:00 -0400 AGN AGNPF AGW0 GREY O.31280495 http://www.streetinsider.com/Press+Releases/Grey+Matters+Health+Signs+LOI+with+Catalyst+MedTech+for+200+Brain+PET+Scans+for+Alzheimer%E2%80%99s+Clinical+Trial+at+2nd+NovaScan+Location+Planned+for+Tampa/26524610.html <p align="justify">VANCOUVER, British Columbia, May 20, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the “<strong>Company</strong>” or “<strong>Grey Matters</strong>”) (CSE: GREY) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company, is pleased to announce that it has signed a non-binding Letter of Intent (LOI) with Catalyst MedTech (Catalyst), to provide a minimum of 200 brain Positron Emission Tomography (PET) scans for an upcoming Alzheimer’s Disease (AD) clinical trial, to be conducted by an international Contract Research Organization (CRO) specializing in AD research. The PET Scans will be performed at the Company’s NovaScan Neuroimaging Clinics™ second location planned for Tampa, Florida. http://www.streetinsider.com/Press+Releases/Grey+Matters+Health+Signs+LOI+with+Catalyst+MedTech+for+200+Brain+PET+Scans+for+Alzheimer%E2%80%99s+Clinical+Trial+at+2nd+NovaScan+Location+Planned+for+Tampa/26524610.html Wed, 20 May 2026 07:00:00 -0400 AGN AGNPF AGW0 GREY O.31280495 http://www.streetinsider.com/Press+Releases/Grey+Matters+Health+Signs+LOI+with+Catalyst+MedTech+for+200+Brain+PET+Scans+for+Alzheimer%E2%80%99s+Clinical+Trial+at+2nd+NovaScan+Location+Planned+for+Tampa/26524610.html <p align="justify">VANCOUVER, British Columbia, May 20, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the “<strong>Company</strong>” or “<strong>Grey Matters</strong>”) (CSE: GREY) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company, is pleased to announce that it has signed a non-binding Letter of Intent (LOI) with Catalyst MedTech (Catalyst), to provide a minimum of 200 brain Positron Emission Tomography (PET) scans for an upcoming Alzheimer’s Disease (AD) clinical trial, to be conducted by an international Contract Research Organization (CRO) specializing in AD research. The PET Scans will be performed at the Company’s NovaScan Neuroimaging Clinics™ second location planned for Tampa, Florida. http://www.streetinsider.com/Press+Releases/Grey+Matters+Health+Signs+LOI+with+Catalyst+MedTech+for+200+Brain+PET+Scans+for+Alzheimer%E2%80%99s+Clinical+Trial+at+2nd+NovaScan+Location+Planned+for+Tampa/26524610.html Wed, 20 May 2026 07:00:00 -0400 AGN AGNPF AGW0 GREY O.31280495 http://www.streetinsider.com/Press+Releases/Grey+Matters+Health+Signs+LOI+with+Catalyst+MedTech+for+200+Brain+PET+Scans+for+Alzheimer%E2%80%99s+Clinical+Trial+at+2nd+NovaScan+Location+Planned+for+Tampa/26524610.html <p align="justify">VANCOUVER, British Columbia, May 20, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the “<strong>Company</strong>” or “<strong>Grey Matters</strong>”) (CSE: GREY) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company, is pleased to announce that it has signed a non-binding Letter of Intent (LOI) with Catalyst MedTech (Catalyst), to provide a minimum of 200 brain Positron Emission Tomography (PET) scans for an upcoming Alzheimer’s Disease (AD) clinical trial, to be conducted by an international Contract Research Organization (CRO) specializing in AD research. The PET Scans will be performed at the Company’s NovaScan Neuroimaging Clinics™ second location planned for Tampa, Florida. http://www.streetinsider.com/Press+Releases/Grey+Matters+Health+Signs+LOI+with+Catalyst+MedTech+for+200+Brain+PET+Scans+for+Alzheimer%E2%80%99s+Clinical+Trial+at+2nd+NovaScan+Location+Planned+for+Tampa/26524610.html Wed, 20 May 2026 07:00:00 -0400 AGN AGNPF AGW0 GREY O.31280495 http://www.streetinsider.com/Press+Releases/Grey+Matters+Health+Signs+LOI+with+Catalyst+MedTech+for+200+Brain+PET+Scans+for+Alzheimer%E2%80%99s+Clinical+Trial+at+2nd+NovaScan+Location+Planned+for+Tampa/26524610.html <p align="justify">VANCOUVER, British Columbia, May 20, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the “<strong>Company</strong>” or “<strong>Grey Matters</strong>”) (CSE: GREY) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company, is pleased to announce that it has signed a non-binding Letter of Intent (LOI) with Catalyst MedTech (Catalyst), to provide a minimum of 200 brain Positron Emission Tomography (PET) scans for an upcoming Alzheimer’s Disease (AD) clinical trial, to be conducted by an international Contract Research Organization (CRO) specializing in AD research. The PET Scans will be performed at the Company’s NovaScan Neuroimaging Clinics™ second location planned for Tampa, Florida. http://www.streetinsider.com/Press+Releases/Grey+Matters+Health+Signs+LOI+with+Catalyst+MedTech+for+200+Brain+PET+Scans+for+Alzheimer%E2%80%99s+Clinical+Trial+at+2nd+NovaScan+Location+Planned+for+Tampa/26524610.html Wed, 20 May 2026 07:00:00 -0400 AGN AGNPF AGW0 GREY O.31280495 http://www.streetinsider.com/Globe+Newswire/Grey+Matters+Health+Signs+LOI+with+Catalyst+MedTech+for+200+Brain+PET+Scans+for+Alzheimer%E2%80%99s+Clinical+Trial+at+2nd+NovaScan+Location+Planned+for+Tampa/26524610.html <p align="justify">VANCOUVER, British Columbia, May 20, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the “<strong>Company</strong>” or “<strong>Grey Matters</strong>”) (CSE: GREY) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company, is pleased to announce that it has signed a non-binding Letter of Intent (LOI) with Catalyst MedTech (Catalyst), to provide a minimum of 200 brain Positron Emission Tomography (PET) scans for an upcoming Alzheimer’s Disease (AD) clinical trial, to be conducted by an international Contract Research Organization (CRO) specializing in AD research. The PET Scans will be performed at the Company’s NovaScan Neuroimaging Clinics™ second location planned for Tampa, Florida. http://www.streetinsider.com/Globe+Newswire/Grey+Matters+Health+Signs+LOI+with+Catalyst+MedTech+for+200+Brain+PET+Scans+for+Alzheimer%E2%80%99s+Clinical+Trial+at+2nd+NovaScan+Location+Planned+for+Tampa/26524610.html Wed, 20 May 2026 07:00:00 -0400 AGN AGNPF AGW0 GREY O.31280495 http://www.streetinsider.com/Globe+Newswire/Grey+Matters+Health+Signs+LOI+with+Catalyst+MedTech+for+200+Brain+PET+Scans+for+Alzheimer%E2%80%99s+Clinical+Trial+at+2nd+NovaScan+Location+Planned+for+Tampa/26524610.html <p align="justify">VANCOUVER, British Columbia, May 20, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the “<strong>Company</strong>” or “<strong>Grey Matters</strong>”) (CSE: GREY) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company, is pleased to announce that it has signed a non-binding Letter of Intent (LOI) with Catalyst MedTech (Catalyst), to provide a minimum of 200 brain Positron Emission Tomography (PET) scans for an upcoming Alzheimer’s Disease (AD) clinical trial, to be conducted by an international Contract Research Organization (CRO) specializing in AD research. The PET Scans will be performed at the Company’s NovaScan Neuroimaging Clinics™ second location planned for Tampa, Florida. http://www.streetinsider.com/Globe+Newswire/Grey+Matters+Health+Signs+LOI+with+Catalyst+MedTech+for+200+Brain+PET+Scans+for+Alzheimer%E2%80%99s+Clinical+Trial+at+2nd+NovaScan+Location+Planned+for+Tampa/26524610.html Wed, 20 May 2026 07:00:00 -0400 AGN AGNPF AGW0 GREY O.31280495 http://www.streetinsider.com/Globe+Newswire/Grey+Matters+Health+Signs+LOI+with+Catalyst+MedTech+for+200+Brain+PET+Scans+for+Alzheimer%E2%80%99s+Clinical+Trial+at+2nd+NovaScan+Location+Planned+for+Tampa/26524610.html <p align="justify">VANCOUVER, British Columbia, May 20, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the “<strong>Company</strong>” or “<strong>Grey Matters</strong>”) (CSE: GREY) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company, is pleased to announce that it has signed a non-binding Letter of Intent (LOI) with Catalyst MedTech (Catalyst), to provide a minimum of 200 brain Positron Emission Tomography (PET) scans for an upcoming Alzheimer’s Disease (AD) clinical trial, to be conducted by an international Contract Research Organization (CRO) specializing in AD research. The PET Scans will be performed at the Company’s NovaScan Neuroimaging Clinics™ second location planned for Tampa, Florida. http://www.streetinsider.com/Globe+Newswire/Grey+Matters+Health+Signs+LOI+with+Catalyst+MedTech+for+200+Brain+PET+Scans+for+Alzheimer%E2%80%99s+Clinical+Trial+at+2nd+NovaScan+Location+Planned+for+Tampa/26524610.html Wed, 20 May 2026 07:00:00 -0400 AGN AGNPF AGW0 GREY O.31280495 http://www.streetinsider.com/Globe+Newswire/Grey+Matters+Health+Signs+LOI+with+Catalyst+MedTech+for+200+Brain+PET+Scans+for+Alzheimer%E2%80%99s+Clinical+Trial+at+2nd+NovaScan+Location+Planned+for+Tampa/26524610.html <p align="justify">VANCOUVER, British Columbia, May 20, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the “<strong>Company</strong>” or “<strong>Grey Matters</strong>”) (CSE: GREY) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company, is pleased to announce that it has signed a non-binding Letter of Intent (LOI) with Catalyst MedTech (Catalyst), to provide a minimum of 200 brain Positron Emission Tomography (PET) scans for an upcoming Alzheimer’s Disease (AD) clinical trial, to be conducted by an international Contract Research Organization (CRO) specializing in AD research. The PET Scans will be performed at the Company’s NovaScan Neuroimaging Clinics™ second location planned for Tampa, Florida. http://www.streetinsider.com/Globe+Newswire/Grey+Matters+Health+Signs+LOI+with+Catalyst+MedTech+for+200+Brain+PET+Scans+for+Alzheimer%E2%80%99s+Clinical+Trial+at+2nd+NovaScan+Location+Planned+for+Tampa/26524610.html Wed, 20 May 2026 07:00:00 -0400 AGN AGNPF AGW0 GREY O.31280495 http://www.streetinsider.com/Globe+Newswire/Grey+Matters+Health+Signs+LOI+with+Catalyst+MedTech+for+200+Brain+PET+Scans+for+Alzheimer%E2%80%99s+Clinical+Trial+at+2nd+NovaScan+Location+Planned+for+Tampa/26524610.html <p align="justify">VANCOUVER, British Columbia, May 20, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the “<strong>Company</strong>” or “<strong>Grey Matters</strong>”) (CSE: GREY) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company, is pleased to announce that it has signed a non-binding Letter of Intent (LOI) with Catalyst MedTech (Catalyst), to provide a minimum of 200 brain Positron Emission Tomography (PET) scans for an upcoming Alzheimer’s Disease (AD) clinical trial, to be conducted by an international Contract Research Organization (CRO) specializing in AD research. The PET Scans will be performed at the Company’s NovaScan Neuroimaging Clinics™ second location planned for Tampa, Florida. http://www.streetinsider.com/Globe+Newswire/Grey+Matters+Health+Signs+LOI+with+Catalyst+MedTech+for+200+Brain+PET+Scans+for+Alzheimer%E2%80%99s+Clinical+Trial+at+2nd+NovaScan+Location+Planned+for+Tampa/26524610.html Wed, 20 May 2026 07:00:00 -0400 AGN AGNPF AGW0 GREY O.31280495 http://www.streetinsider.com/Press+Releases/Aegon+publishes+agenda+for+2026+Annual+General+Meeting/26386293.html <p>Schiphol, April 29, 2026 - <br/>Aegon has today published the agenda for its Annual General Meeting of Shareholders (AGM), scheduled for Wednesday, June 10, 2026. The related meeting materials, including the agenda, are now available on <a target="_blank" href="https://www.globenewswire.com/Tracker?data=iSHpnChS3CFWvFfYgxOqm-ypBRxrt43hxPIlFwqJtgb18CppO-2xIoxGZD4Q0d4zIW64m-ix-jx_HLIiMFK3LWiQMX0boDBTdh4F_-3-WKcT5dxexfxMSq-FE4a0K0h45Bk2fMsg2wfGQrv86vEsaIXJToglA8LlR0C4cjBTkGLuRFrm7G79Csblx5tDmzGR" rel="nofollow" target="_blank">the dedicated Aegon AGM webpage</a>.</p> <p>At the AGM, the Board of Directors will present the 2025 Annual Accounts and propose a final dividend of EUR 0.21 per common share. This brings the total dividend for 2025 to EUR 0.40 per common share. </p> <p>The agenda also covers several proposals relating to the composition of the Board of Directors. This http://www.streetinsider.com/Press+Releases/Aegon+publishes+agenda+for+2026+Annual+General+Meeting/26386293.html Wed, 29 Apr 2026 02:00:00 -0400 0Q0Y 50OR A.09642568 AEG AGN O.00187864 O.20371933 http://www.streetinsider.com/Press+Releases/Aegon+publishes+agenda+for+2026+Annual+General+Meeting/26386293.html <p>Schiphol, April 29, 2026 - <br/>Aegon has today published the agenda for its Annual General Meeting of Shareholders (AGM), scheduled for Wednesday, June 10, 2026. The related meeting materials, including the agenda, are now available on <a target="_blank" href="https://www.globenewswire.com/Tracker?data=iSHpnChS3CFWvFfYgxOqm-ypBRxrt43hxPIlFwqJtgb18CppO-2xIoxGZD4Q0d4zIW64m-ix-jx_HLIiMFK3LWiQMX0boDBTdh4F_-3-WKcT5dxexfxMSq-FE4a0K0h45Bk2fMsg2wfGQrv86vEsaIXJToglA8LlR0C4cjBTkGLuRFrm7G79Csblx5tDmzGR" rel="nofollow" target="_blank">the dedicated Aegon AGM webpage</a>.</p> <p>At the AGM, the Board of Directors will present the 2025 Annual Accounts and propose a final dividend of EUR 0.21 per common share. This brings the total dividend for 2025 to EUR 0.40 per common share. </p> <p>The agenda also covers several proposals relating to the composition of the Board of Directors. This http://www.streetinsider.com/Press+Releases/Aegon+publishes+agenda+for+2026+Annual+General+Meeting/26386293.html Wed, 29 Apr 2026 02:00:00 -0400 0Q0Y 50OR A.09642568 AEG AGN O.00187864 O.20371933